The American biotech company Moderna said Monday that its potential vaccine against the coronavirus is 94.5% effective in fighting the virus, according to an initial analysis published by the group based in Cambridge, Massachusetts.
The Moderna vaccine -alongside the equally effective candidate from Pfizer- offers another beacon of hope for bringing the pandemic currently raging across the globe.
Carried out in collaboration with the US National Institute of Health, Moderna’s study involved 3,000 participants – half of whom received a placebo. In 95 cases of Covid-19 that developed among the participants, 90 were taking the placebo. Moderna reports that there have been no major safety issues so far.
According to Dr. Anthony Fauci, an American immunologist, “This is very good news. If you look at the data, the numbers speak for themselves.”
“I describe myself as a realist, but I’m basically a cautious optimist. I felt we would probably have less than that. … I said that a vaccine that was over 90% effective was certainly possible, but I wasn’t thinking about it,” he added.
This announcement comes a week after another US laboratory, Pfizer and German BioNTecha, which announced that they had resulted in a vaccine “90% effective” against Covid-19.